SLP Form 4: Director Acquires 2,074 Shares, Sells 867 at $12.93

[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Simulations Plus, Inc. (SLP) 鈥� Form 4 insider filing

Director Lisa LaVange disclosed two transactions on 08/01/2025:

Equity grant: 2,074 common shares awarded under the 2021 Equity Incentive Plan at a deemed price of $0, lifting her stake to 10,797 shares.
Rule 10b5-1 sale: 867 common shares sold at $12.93 per share in a single automatic trade, trimming direct ownership to 9,930 shares.

No derivative securities were involved, and the filing was executed by attorney-in-fact Daniel Hoeft on 08/04/2025.

Insights

TL;DR: Minor director sale offset by stock grant; negligible net ownership change鈥攊mpact appears neutral.

The filing shows Ms. LaVange received 2,074 shares as routine board compensation and subsequently sold 867 shares at $12.93 via a pre-set Rule 10b5-1 plan. Post-trade direct holdings stand at 9,930 shares, down only 8% from the intra-day peak of 10,797. No derivatives or unusual activity are reported. Given the modest size relative to her total stake and lack of material information about company operations, the market impact should be limited.

08/04/2025 - 04:21 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chi Michael

(Last)

(First)

(Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO

94123

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	07/31/2025		M⁽¹⁾		3,600	A	$13.9	282,254	D
Class A Common Stock	07/31/2025		M⁽¹⁾		14,700	A	$5.01	296,954	D
Class A Common Stock	07/31/2025		M⁽¹⁾		6,300	A	$6.82	303,254	D
Class A Common Stock	07/31/2025		M⁽¹⁾		1,750	A	$11.53	305,004	D
Class A Common Stock	07/31/2025		S⁽¹⁾		26,350	D	$67	278,654	D
Class A Common Stock	08/01/2025		M⁽¹⁾		250	A	$11.53	278,904	D
Class A Common Stock	08/01/2025		S⁽¹⁾		250	D	$64.44	278,654	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$13.9	07/31/2025		M⁽¹⁾			3,600	⁽²⁾	05/27/2031	Class A Common Stock	3,600	$0	7,800	D
Stock Option (right to buy)	$5.01	07/31/2025		M⁽¹⁾			14,700	⁽³⁾	02/24/2032	Class A Common Stock	14,700	$0	178,242	D
Stock Option (right to buy)	$6.82	07/31/2025		M⁽¹⁾			6,300	⁽⁴⁾	08/10/2032	Class A Common Stock	6,300	$0	118,062	D
Stock Option (right to buy)	$11.53	07/31/2025		M⁽¹⁾			1,750	⁽⁵⁾	03/01/2033	Class A Common Stock	1,750	$0	47,856	D
Stock Option (right to buy)	$11.53	08/01/2025		M⁽¹⁾			250	⁽⁵⁾	03/01/2033	Class A Common Stock	250	$0	47,606	D

Explanation of Responses:

1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025 by the Reporting Person.

2. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the options vesting on April 19, 2022 and the remaining 75% of the options vesting monthly thereafter.

3. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on March 24, 2022, and 1/48th of the options vesting monthly thereafter.

4. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on September 10, 2022, and 1/48th of the options vesting monthly thereafter.

5. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.

Remarks:

	/s/ Alexandra Cotter Wilkins, Attorney-in-Fact	08/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

AG真人官方

[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Insights

NYSE:HIMS

HIMS Rankings

HIMS Latest News

HIMS Latest SEC Filings

HIMS Stock Data

AG真人官方

Trending News

[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Insights

Securities Analyst neutral

NYSE:HIMS

HIMS Rankings

HIMS Latest News

HIMS Latest SEC Filings

HIMS Stock Data